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Application of eligibility criteria 
Inclusion: Patients aged ≥ 65; taking ≥  5 medicines 
Exclusion: no record of medical diagnoses 
II Granada Consensus (1):  
Necessity  DRP 1: untreated condition 
 DRP 2: unnecessary medicine  
Effectiveness  DRP 3: non-quantitative ineffectiveness 
 DRP 4: quantitative ineffectiveness 
Safety  DRP 5: non-quantitative unsafety 
 DRP 6: quantitative unsafety 
Pharmacist-led medication review proved useful in 
identifying DRP in elderly polypharmacy patients. The 
acceptance rate of pharmacist’s reports is far from ideal 
but may be justified by this project’s unexpected impact 
on media coverage, which led to nursing homes being 
less receptive to admit flaws in their system. Meetings 
will be held with the facility that withheld information 
with the purpose of developing stronger bonds 
between healthcare providers involved.  
The numerous comorbidities associated with ageing 
often    lead to treatment with multiple drugs. 
Pharmacist-led medication review of polypharmacy  
patients may play an important role in the detection of 
Drug Related Problems (DRP), thus contributing to their 
prevention or solution. 
To determine the prevalence of real and potential DRP in 
polypharmacy elderly residing in nursing homes; and to 
describe the nature of DRP; and to explore acceptance of 
pharmacists’ reports. 
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Statistical Analysis: Univariate. Bivariate: Mann-Whitney, 
Student’s T-Test; Pearson’s correlation coefficient. 95% CI. 
Table 1 Total IG  CG  
 
p 
Age 126 85,16 (6,302) 84,46 (5,978) 0,525 
Medicines 1332 10,78 (4,556) 10,37 (3,858) 0,584 
DRP 2109 13,50 (9,19) 16 (7,510) 0,252 
Table 1 presents the sample main characteristics at 
baseline. The number of medicines directly correlated 
with the number of DRP detected (Fig 1). Flowchart 1 
summarises interventions made and results obtained. 
Figure 1 
Real DRP = 29 (31.8% IG) 
DRP 4 = 18 (40.0%)  
Potential DRP = 1001 (100.0% IG) 
DRP 5 = 385 (18.7%) 
DRP 2 =  277 (13.4%)  
Reported= 584 (56.7%) 
62 suggestions of 
therapy change  
Interventions accepted = 10/28 (35.7%) 
No feedback =  34  (54.8%) 
Identified at baseline Pharmacist intervention 
Physician’s acceptance 
Flowchart 1 
